Rapid Molecular Tests for Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses: A Systematic Review of Diagnostic Accuracy and Clinical Impact Studies

Clinical Infectious Diseases

Volumn 69, Issue 7, 2019, Pages 1243-1253

  Vos, Laura M ^a   Bruning, Andrea H L ^b   Reitsma, Johannes B ^c   Schuurman, Rob ^a   Riezebos Brilman, Annelies ^a   Hoepelman, Andy I M ^a   Oosterheert, Jan Jelrik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Julius Center for Health Sciences and Primary Care   (Netherlands)

Author keywords

diagnostic accuracy; impact; molecular diagnostics; rapid test; review

Indexed keywords

OSELTAMIVIR;

ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; CLINICAL OUTCOME; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HOSPITAL READMISSION; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; ISOLATION FACILITY; LENGTH OF STAY; MOLECULAR DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; QUALITY ASSESSMENT OF DIAGNOSTIC ACCURACY STUDIES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; ALGORITHM; CLINICAL DECISION MAKING; DISEASE MANAGEMENT; PROCEDURES; REPRODUCIBILITY; RESPIRATORY TRACT INFECTION; VIROLOGY;

ALGORITHMS; CLINICAL DECISION-MAKING; DISEASE MANAGEMENT; HUMANS; INFLUENZA, HUMAN; MOLECULAR DIAGNOSTIC TECHNIQUES; REPRODUCIBILITY OF RESULTS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 85064412261     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciz056     Document Type: Review

References (48)

1. Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 2017; 5:401-11.
2. Zumla A, Al-Tawfiq JA, Enne VI, et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections-needs, advances, and future prospects. Lancet Infect Dis 2014; 14:1123-35.
3. Clark T W, Medina MJ, Batham S, Curran MD, Parmar S, Nicholson KG. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect 2014; 69:507-15.
4. Brendish NJ, Schiff H F, Clark T W. Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Infect 2015; 71:501-10.
5. Jain S, Williams DJ, Arnold SR, et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 2015; 372:835-45.
6. Oosterheert JJ, van Loon AM, Schuurman R, et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 2005; 41:1438-44.
7. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757-62.
8. Smith SM, Fahey T, Smucny J, Becker L. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2014; 3:CD000245.
9. McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014; 12:252-62.
10. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62:1-9.
11. Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase poly-merase chain reaction. Ann Intern Med 2017; 167:395-409.
12. Bruning A, Leeflang M, Vos J, et al. Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clin Infect Dis 2017; 65:1026-32.
13. Chartrand C, Tremblay N, Renaud C, Papenburg J. Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis. J Clin Microbiol 2015; 53:3738-49.
14. Babady NE. The FilmArray respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn 2013; 13:779-88.
15. Salez N, Nougairede A, Ninove L, Zandotti C, de Lamballerie X, Charrel RN. Xpert Flu for point-of-care diagnosis of human influenza in industrialized coun-tries. Expert Rev Mol Diagn 2014; 14:411-8.
16. Deeks JJ, Bossuyt PM, Gatsonis C, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy version 1.0. 2010. Available at: http://srdta.cochrane.org/. Accessed 9 February 2017.
17. Whiting PF, Rutjes AWS, Westwood ME, et al. Research and reporting methods accuracy studies. Ann Intern Med 2011; 155:529-36.
18. Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343:1-9.
19. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355:4-10.
20. Andrews D, Chetty Y, Cooper BS, et al. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use. BMC Infect Dis 2017; 17:1-11.
21. Branche AR, Walsh EE, Vargas R, et al. Serum procalcitonin measurement and viral testing to guide antibiotic use for respiratory infections in hospitalized adults: a randomized controlled trial. J Infect Dis 2015; 212:1692-700.
22. Busson L, Mahadeb B, De Foor M, Vandenberg O, Hallin M. Contribution of a rapid influenza diagnostic test to manage hospitalized patients with suspected influenza. Diagn Microbiol Infect Dis 2017; 87:238-42.
23. Chu HY, Englund JA, Huang D, et al. Impact of rapid influenza PCR testing on hospitalization and antiviral use: a retrospective cohort study. J Med Virol 2015; 87:2021-6.
24. Gilbert D, Gelfer G, Wang L, et al. The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia. Diagn Microbiol Infect Dis 2016; 86:102-7.
25. Gelfer G, Leggett J, Myers J, Wang L, Gilbert DN. The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia. Diagn Microbiol Infect Dis 2015; 83:400-6.
26. Linehan E, Brennan M, O'Rourke S, et al. Impact of introduction of Xpert flu assay for influenza PCR testing on obstetric patients: a quality improvement project. J Matern Fetal Neonatal Med 2018; 31:1016-20.
27. Pettit NN, Matushek S, Charnot-Katsikas A, et al. Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies. J Med Microbiol 2015; 64:312-3.
28. Rappo U, Schuetz AN, Jenkins SG, et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol 2016; 54:2096-103.
29. Rogers BB, Shankar P, Jerris RC, et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med 2015; 139:636-41.
30. Timbrook T, Maxam M, Bosso J. Antibiotic discontinuation rates associated with positive respiratory viral panel and low procalcitonin results in proven or suspected respiratory infections. Infect Dis Ther 2015; 4:297-306.
31. Xu M, Qin X, Astion ML, et al. Implementation of FilmArray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol 2013; 139:118-23.
32. Muller M P, Junaid S, Matukas LM. Reduction in total patient isolation days with a change in influenza testing methodology. Am J Infect Control 2016; 44:1346-9.
33. Keske S, Ergönül Ö, Tutucu F, Karaaslan D, Palaoglu E, Can F. The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs. Eur J Clin Microbiol Infect Dis 2018; 37:779-83.
34. Ducharme FM, Zemek R, Chauhan B, et al. Determinants of oral corticosteroid responsiveness in wheezing asthmatic youth (doorway): a multicentre prospective cohort study of children with acute moderate or severe asthma exacerbations. Am J Respir Crit Care Med 2015; 191:S314-5.
35. Granados A, Peci A, McGeer A, Gubbay JB. Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections. J Clin Virol 2017; 86:14-9.
36. Cohen-Bacrie S, Halfon P. Prospects for molecular point-of-care diagnosis of lower respiratory infections at the hospital's doorstep. Future Virol 2013; 8:43-56.
37. Doan Q, Enarson P, Kissoon N, Klassen T P, Johnson D W. Rapid viral diagnosis for acute febrile respiratory illness in children in the emergency department. Cochrane Database Syst Rev 2009; 4:CD006452.
38. Huang HS, Tsai CL, Chang J, Hsu TC, Lin S, Lee CC. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect 2018; 24:1055-63.
39. Chartrand C, Leeflang MM, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med 2012; 156:500-11.
40. Moore C. Point-of-care tests for infection control: should rapid testing be in the laboratory or at the front line? J Hosp Infect 2013; 85:1-7.
41. Vos LM, Riezebos-Brilman A, Hoepelman AIM, Oosterheert JJ. Rapid tests for common respiratory viruses. Clin Infect Dis 2017; 65:1958-9.
42. Gaunt ER, Harvala H, McIntyre C, Templeton KE, Simmonds P. Disease burden of the most commonly detected respiratory viruses in hospitalized patients calculated using the disability adjusted life year (DALY) model. J Clin Virol 2011; 52:215-21.
43. McKimm-Breschkin JL, Jiang S, Hui DS, Beigel JH, Govorkova EA, Lee N. Prevention and treatment of respiratory viral infections: presentations on anti-virals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference. Antiviral Res 2018; 149:118-42.
44. Vallières E, Renaud C. Clinical and economical impact of multiplex respiratory virus assays. Diagn Microbiol Infect Dis 2013; 76:255-61.
45. Ko F, Drews SJ. The impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization. Expert Rev Mol Diagn 2017; 17:917-31.
46. Egilmezer E, Walker GJ, Bakthavathsalam P, et al. Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection. Rev Med Virol 2018; 28:1995.
47. van Houten CB, de Groot JAH, Klein A, et al. A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study. Lancet Infect Dis 2017; 17:431-40.
48. Kim C, Ahmed JA, Eidex RB, et al. Comparison of nasopharyngeal and oropha-ryngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS One 2011; 6:2-7.